Please login to the form below
KOL Strategy
This page shows the latest KOL Strategy news and features for those working in and with pharma, biotech and healthcare.
New accounts: September
Aranesp KOL strategy. Oncology. central. Amgen European HQ. Mimpara meetings. Nephrology. ... central. Amgen European HQ. Neulasta KOL strategy. Oncology. central. Baxter Healthcare UK.
Latest news
-
New accounts: October
Amgen European HQ. Aranesp KOL strategy. Oncology. central. Amgen European HQ. ... Mimpara meetings. Nephrology. central. Amgen European HQ. Neulasta KOL strategy. Oncology.
-
New accounts: November
Allergan. Botox. Neurology. Jango Communications. Amgen European HQ. Aranesp KOL strategy. ... Neulasta KOL strategy. Oncology. central. GlaxoSmithKline. Cervarix. Cervical cancer (consumer healthcare).
More from news
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
emotive. expands Medical Writing and Client Services teams
She brings a breadth of knowledge in pre-launch strategy and tactical implementation, KOL development, patient engagement, disease awareness and CME programmes, working with both marketing and medical clients.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Regeneron says antibody for COVID-19 could be ready this year
- EMA clears BMS’ oral multiple sclerosis drug Zeposia
- GSK plans to produces one billion doses of vaccine adjuvant for COVID-19
- Guiding star of science leads AstraZeneca to breakthrough in child tumour therapy
- Alnylam and Vir plan gene-silencing attack on COVID-19 virus
- New data backs remdesivir for COVID-19, but rings hydroxychloroquine alarm bell
- Lilly starts world first trial of an antibody drug for COVID-19
- Pfizer’s Ibrance misses the mark in early breast cancer
- Rise of the patient influencer
- Working together against COVID-19
- Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
- ASCO: Merck’s Keytruda tops chemo in MSI-H colorectal cancer
PMHub
McCann Health Medical Communications
We are the medical communications experts within McCann Health. Communicating science to bring meaning and positive change to people’s lives....
Latest intelligence
- Working together against COVID-19
- Analysing social media conversations to see what HCPs are saying online about the global pandemic...
- Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
- Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
- Are biobetters a market access opportunity?
- Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....
Quick links
Infographics
